MMP9 and central nervous system cancer: We anticipate that these interactions among MMP9, uPAR, cathepsin B and β1 integrin demonstrate β1 integrin-mediated ECM signaling in reduced activity of NHEJ in pMU- and pMC-treated 4910 and 5310 glioma xenograft cells compared to untreated cells.